newsfilter
← Latest News
Business Wire·

Revance Reports Second Quarter 2024 Financial Results, Provides Corporate Update

- Q2 total DAXXIFY® and RHA® (by Teoxane SA) product revenue of $65.3 million, a YoY increase of 20%. - Q2 DAXXIFY net revenue of $28.7 million, a YoY increase of 27%. - Q2 DAXXIFY aesthetic units sold